TSS
PBE icon

Two Sigma Securities’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Two Sigma Securities’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,522
Closed -$226K – 1935
2017
Q3 		$226K Buy
+4,522
New +$214K 0.02% 524

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAS
Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

Two Sigma Securities's PBE Position: Q4 2017 in Review

Two Sigma Securities sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2017, closing a stake of 4,522 shares — an estimated $226K sold.

Two Sigma Securities first reported a position in PBE in Q3 2017 and held it in 1 quarter. The position peaked at $226K in Q3 2017. 69 funds tracked by Wall St. Rank hold PBE as of Q4 2017.

  • Two Sigma Securities reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2017 after selling out during the quarter.
  • Two Sigma Securities sold 4,522 Invesco Biotechnology & Genome ETF shares in Q4 2017, an estimated $226K.
  • Two Sigma Securities first reported a position in Invesco Biotechnology & Genome ETF in Q3 2017 and held it in 1 quarter.
  • Two Sigma Securities's Invesco Biotechnology & Genome ETF position peaked at $226K in Q3 2017.
  • 69 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2017.

Based on Two Sigma Securities's 13F filing for Q4 2017, filed 14 Feb 2018.